Fingerprint
Dive into the research topics of 'Is symptom duration before DMARD therapy a determinant of direct and indirect costs in DMARD-naïve RA patients?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Is symptom duration before DMARD therapy a determinant of direct and indirect costs in DMARD-naïve RA patients?
Ilfita Sahbudin*, Ruchir Singh, Jen Trickey, Aliaksandra Baranskaya, Alexander Tracy, Karim Raza, Andrew Filer, Sue Jowett, Annelies Boonen
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
13
Downloads
(Pure)